IN-light
ME/CFS is a serious condition that can have a major impact on daily life, as the body struggles to produce energy. This often leads to fatigue, muscle weakness and concentration problems. With IN-light's intranasal red light therapy, it is possible to stimulate energy production in the cells, improve blood circulation and support the body's recovery. Here you can read how IN-light can help reduce symptoms and promote well-being in ME/CFS.
Red light therapy from IN-light can help with ME/CFS in various ways. The red light uses photobiomodulation to stimulate cells. Because the laser is used intranasally (via the nose), it reaches the cells and thus the entire body via the bloodstream. This is exactly how it works with ME/CFS:
Photobiomodulation stimulates the mitochondria in the cells. These are the “powerhouses” of the cell. This allows cells to function better, recover faster and gain more energy.
The red light improves microcirculation, which helps transport oxygen and nutrients. There is also a higher NO release, which improves blood flow.
Red light therapy reduces the accumulation of harmful free radicals. It reduces ROS and improves redox balance.
Intranasal photobiomodulation can reduce inflammatory responses in the body by supporting the immune system. This helps restore balance in the immune system and can contribute to better regulation of the natural defence system, enabling the body to respond more effectively to stress and infections.
Improved microcirculation, more efficient use of oxygen for energy, better blood flow and oxygen transport, and improved flexibility of red blood cells all contribute to better oxygen availability in the body.
The above effects have many potential benefits. Below you can read what you may notice.
Using the IN-light Pro for ME/CFS can offer many benefits. Here is what the laser can do for you:
How often
How long
Treatment period
1-2 times a day
30 minutes
As long as necessary. We recommend continuing to use the IN-light, as it can also offer other health benefits.
Intranasal photobiomodulation (red light therapy via the nose) uses low-level light. This light is often red or near-infrared and helps to stimulate cellular processes and reduce inflammation. Studies show that PBM:
Many patients notice improvements after just a few treatments, but this can vary from person to person. Every body is different. It is therefore impossible to say in advance when you will see results. We recommend that you use the laser for a while first.
Yes, the intranasal laser is safe and painless. It is a non-invasive therapy that has been used for many years.
For best results, we recommend using the laser twice a day, with at least 6 hours of rest between sessions. You can build this up gradually during the first week. It is also important to use the laser consistently. This allows your body to get used to red light therapy. With the help of the manual, you can determine exactly how long a session should be based on your weight. After a while, you can go back to once a day for a maximum of 30 minutes.
ME/CFS is a complex condition in which the central nervous system and immune system are disrupted, and energy metabolism in the cells is disturbed. As a result, patients experience extreme fatigue, muscle weakness and problems with cognitive functions. Many patients also have additional conditions, such as fibromyalgia. Millions of people in Europe have ME/CFS, and many Long COVID patients meet the same criteria.
Research shows that a core problem in ME/CFS is the mitochondria, the energy factories of the cell. In patients, these mitochondria function less effectively, causing the cells to produce less energy (ATP), especially under stress. This leads to typical symptoms such as fatigue, poor muscle strength and delayed recovery after exertion. This mitochondrial dysfunction and disruption of energy metabolism shows great similarities with Long COVID.
Scientific studies show that ME/CFS involves, among other things:
Intranasal laser therapy, such as IN-light, can support mitochondrial function. Research shows that light therapy can increase energy production (ATP) and improve oxygen levels in the blood. This partly explains the positive effects that patients with ME/CFS and Long COVID experience with this treatment.
In summary: there is strong evidence that mitochondrial dysfunction plays a central role in ME/CFS and Long COVID, and that photobiomodulation via intranasal laser therapy may be a promising supportive approach.
A review on Long COVID concluded that ‘emerging evidence has pointed to mitochondrial dysfunction ... contributing to the persistence and diversity of long COVID symptoms’ (such as fatigue and cognitive problems), including disrupted energy production, oxidative stress and immune dysregulation.
Several studies have also described mitochondrial dysfunction, redox imbalance and disruption of energy metabolism in ME/CFS.
A key sentence from one article: ‘Accumulating data indicates a relationship between redox imbalance, mitochondrial dysfunction ... in patients with ME/CFS ... These abnormalities were also found in patients with Long COVID-19 and suggest that the two disorders may share common pathophysiological features.’
Biomarker studies in Long COVID show abnormalities in mitochondrial gene expression, reduced respiration in cells, and structural mitochondrial abnormalities via electron microscopy.
The IN-light Pro is a high-quality wellness product. All products in this category are intended for daily use to support general health. The IN-light Pro does not make any direct medical claims, as the methodology of red light therapy focuses on the whole body. It is therefore not a treatment for a specific medical condition. The basis for health products is their ability to provide a general well-being or health benefit. A general health benefit is a health-related benefit that is not a treatment for a specific medical condition.
However, scientific evidence and user experiences show that using the IN-light can lead to improvements in specific conditions.
